Latest News
Bristol-Myers Squibb have recently announced the failure of the drug Opdivo® (nivolumab) to show a clinically significant effect in the treatment of small-cell lung cancer.
Find out the key headlines from the ESMO 2018 Congress (19–23 October, Munich, Germany).
Approximately 1 in 4 patients being treated in the community have received DNA matched treatment from comprehensive genomic profiling results, indicating that precision medicine is now increasingly utilized in settings other than specialist hospital environments.
Journal Articles
In this review article from Future Oncology find out about the PACIFIC trial design as well as the future of immunotherapy combinations and biomarkers beyond PD-L1.
A new study, published in CNS Oncology estimates the survival benefit of adding tumor treating fields and temozolomide for newly diagnosed glioblastoma patients.
Immune checkpoint inhibitors revolutionized the treatment of non-small-cell lung cancer, although their costs are a limitation; find out more in this article from Immunotherapy.
Brain and neurologic
Zika vaccine yields promising results for treating glioblastoma
Has the secret of the immortality cancer switch been unlocked?
Breast
What are the top 5 breast cancer advancements of 2018?
Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial
Tamoxifen, SERMs and sustainable medicine: an interview with V. Craig Jordan & Balkees Abderrahman
Colorectal
Data-driven blood test could be a step towards personalized treatment for bowel cancer
Chemicals found in vegetables prevent colon cancer in mice
Colorectal cancer screening age to be lowered to 50 in England
Endocrine
Blood test could detect kidney cancer up to 5 years earlier
FDA approves first-in-class treatment for rare adrenal tumors
Gastrointestinal
A remarkable insight into the cancer journey of Barbara Moss
Conference Chair highlights: World Congress on Gastrointestinal Cancer
Genitourinary
Could urine liquid biopsies help monitor bladder cancer treatment?
NICE approves atezolizumab for advanced bladder cancer patients on the NHS
Gynecologic
Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial
Head and neck
Diabetics face a higher risk of mouth cancer, with women more at risk
The importance of a multidisciplinary team in the care of head and neck cancer
The importance of sentinel lymph node biopsies in the diagnosis of head and neck cancer
Hematologic
Personalized prediction scheme for myeloproliferative neoplasms developed
NHS England strikes deal for ground-breaking CAR-T therapy in a new European first
Lung
It’s checkmate for Opdivo small-cell lung cancer trial
IASLC 19th WCLC: highlights and the biggest headlines
IMpower133: Atezolizumab extends overall survival for extensive-stage small-cell lung cancer
Pancreatic
ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer
ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer
ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer
Prostate
Circulating tumor cells: researchers develop mechanism for characterizing function
Immunotherapy may be an effective therapy for prostate cancer with mismatch repair mutations
Hair loss gene could be exploited to improve cancer immunotherapy
Rare tumors
Osteoblastoma genetic marker shows promise for identifying aggressive tumors
Skin
FDA approves first and only treatment for advanced cutaneous squamous cell carcinoma
NICE approves dabrafenib–trametinib for BRAF+ melanoma
Hair loss gene could be exploited to improve cancer immunotherapy
